Compare SKLZ & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKLZ | ECOR |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.3M | 49.1M |
| IPO Year | 2020 | 2018 |
| Metric | SKLZ | ECOR |
|---|---|---|
| Price | $6.59 | $6.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $14.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 2.5M | 52.3K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $104,496,000.00 | $32,032,000.00 |
| Revenue This Year | $28.27 | $33.60 |
| Revenue Next Year | $11.01 | $30.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 12.52 | ★ 27.20 |
| 52 Week Low | $2.23 | $4.16 |
| 52 Week High | $20.00 | $8.30 |
| Indicator | SKLZ | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 55.14 | 53.81 |
| Support Level | $3.60 | $6.57 |
| Resistance Level | $8.47 | $7.50 |
| Average True Range (ATR) | 2.25 | 0.47 |
| MACD | 0.05 | 0.07 |
| Stochastic Oscillator | 19.58 | 54.36 |
Skillz Inc is a two-sided mobile gaming platform that connects developers with competitive players. The company's reportable business segments are: the Skillz segment and the Aarki segment. Skillz segment's highlights include Monetize Through Competitions, Player Matching, Cross-Platform Support, Comprehensive Analytics, and Focus on Game Development. Aarki is an artificial intelligence company that delivers advertising solutions. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The majority of its revenue is generated from the Skillz segment. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.